$SDGR

Schrodinger Inc

  • NASDAQ
  • Technology Services
  • Packaged Software
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$28.15 β–²1.478%

Extented Hours

VOLUME

354,294

DAY RANGE

26.45 - 27.86

52 WEEK

20.71 - 76.81

Join Discuss about SDGR with like-minded investors

profile
@dros #droscrew
recently

440 $SDGR SEP2022 $40 Cs trade 5.4

71 Replies 15 πŸ‘ 14 πŸ”₯

profile
@dros #droscrew
recently

440 $SDGR SEP2022 $40 Cs trade 5.4

101 Replies 9 πŸ‘ 7 πŸ”₯

profile
@achatzi #ivtrades
recently

GM all > @CarlosH said: Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

135 Replies 6 πŸ‘ 8 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

84 Replies 11 πŸ‘ 7 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

U.S. stock markets are rebounding after major indices fell a second straight day Thursday as consumer price inflation (CPI) data spiked to 30-year highs, renewing fears that the Fed is behind the curve and may need to raise rates quicker. There is no major U.S. economic data, and Bond markets are closed today in observance of the Veteran’s Day Holiday. Sterling hits lowest levels since Dec ’20 vs. the dollar and euro to lowest since July ’20 as the buck surges to more than 1-year highs. In Asian markets, The Nikkei Index rose 171 points to settle at 29,277, the Shanghai Index gained 40 points (1.15%) to settle at 3,532 and the Hang Seng Index gained 1% to finish at 25,247. In Europe, the German DAX is higher by 20 points to 16,090, while the FTSE 100 is up 25 points to 7,365. Investors and traders have been trained to β€œbuy the dip” on any market pullback over the last 2-years, and to this point have been rewarded with all major averages just off their record highs earlier this week. Year-to-date, the Dow is up 17.8%, the S&P 500 up 23.7%, the Nasdaq Composite up 21.2% and the Russell 2000 up 21% in what has been a broad, strong market rally behind better corporate earnings, government stimulus plans, and an easy money policy stance by the Fed. Earnings are finally coming to an end for the quarter, with Dow component Disney (DIS) sliding nearly 5% overnight on its top and bottom-line miss. Market Closing Prices Yesterday The S&P 500 Index slipped -38.54 points, or 0.82%, to 4,646.71 The Dow Jones Industrial Average fell -240.04 points, or 0.66%, to 36,079.94 The Nasdaq Composite dropped -263.84 points, or 1.66%, to 15,622.71 The Russell 2000 Index declined -37.71 points, or 1.55% to 2,389.58 Events Calendar for Today No major U.S. economic data due to Veteran’s Day Holiday Earnings Calendar: Earnings Before the Open: BHG, BKTI, CRC, CRLBF, CSU, EPC, OB, OGN, PGTI, SANW, SBH, SPH, STXS, TPR, TXMD, UTZ, WTT, XOS, YETI Earnings After the Close: ASTR, JAMF, KINS, KRUS, LAZR, LIDR, LTRX, MAPS, OPNT, RPID, SFT Other Key Events: Baird 51st Annual Global Industrial Conference, 11/9-11/12 (virtual) Credit Suisse 30th Annual Healthcare Conference, 11/8-11/11 (virtual) Jefferies 2nd Annual Global Interactive Entertainment Conference, 11/11-11/12 (virtual) JPMorgan Global Consumer, Retail & Luxury Conference, 11/8-11/11 (virtual) Morgan Stanley Global Chemicals, Agriculture & Packaging Conference, 11/10-11/12 (virtual) Piper East Coast Financial Services Conference, 11/10-11/11 (virtual) REITWorld 2021 Annual Conference, 11/9-11/12 (virtual) Society for Immunotherapy of Cancer, 11/10-11/14, in Washington D.C. ==================================================== Sector News Breakdown Consumer Beyond Meat ($BYND) shares slide -15%; 3Q EPS ($0.87) vs est. ($0.39) on revs $106.4Mm vs est. $109.2Mm; guides 4Q revs $85-110Mm vs est. $131.6Mm Lordstown Motors ($RIDE) has agreed to sell to Foxconn the Lordstown facility, excluding certain assets such as the hub motor assembly line and battery module and pack lines, for $230 million. Energy, Industrials and Materials First Solar ($FSLR) shares fell after hours – on news the U.S. will not open an investigation into Asian solar companies that critics warned would drive up costs for clean power and escalate tensions with China, as per Bloomberg. The Commerce Department determined that Asian companies did not sell solar cells β€œat less than normal value,” according to the report Financials Affirm Holdings ($AFRM) Q1 revs $269.4M vs. est. $252.2M; Q1 GMV up 8% QoQ to $2.7B; sees year revs $1.225B-$1.250B vs. est. $1.22B; sees year GMV $13.13B-$13.38B; expands network by increasing active merchants from 6,500 to 102,000 and active consumers by 124% to 8.7M YoY Opendoor Technologies Inc. ($OPEN) shares rise 15%; 3Q EPS ($0.09) vs est. $(0.17) on revs $2.3B vs est. $2B; guides 4Q revs $3.1-3.2B vs est. $2.92B SoFi inc. ($SOFI) shares rise 12%; Q3 EPS loss (-$0.05) vs. est. loss (-$0.14); Q3 revs rose 35% to $272M vs. est. $251.5M; sees Q4 revenue $272M-$282M vs. est. $274.9M and sees year rev $1.0B-$1.01B vs. est. $979.5M; total products 4.3M, a 108% increase and 5th consecutive quarter of triple-digit annual growth; added 377k new members, as SoFi Money, SoFi Invest, and SoFi Credit Card drove 79% of new member growth; sees annual growth accelerating to +49-55% in Q4 from Q3’s +28% ZipRecruiter ($ZIP) Q3 revenue $212.7M vs est. $188.1M, adj EBITDA $42.5M vs est. $14.3M; sees Q4 revenue $203M-$209M vs est. $171.25M raised full-year guidance given business momentum and a strong hiring environment with job seeking activity still below pre-pandemic levels as it now sees FY21 revenue $724M-$730M (est. $667.5M) from $651M-$665M, adj EBITDA $93M-$99M (est. $38.6M) from $30M-$38M Healthcare GoodRx Holdings, Inc. ($GDRX) 3Q adj EPS $0.09 vs est. $0.09 on revs $195.1Mm vs est. $194.9Mm, qtrly monthly active consumers 6.4Mm; guides FY revs $744-754Mm vs est. $748.3Mm Media & Telecom Walt Disney ($DIS) Q4 EPS $0.37 vs. est. $0.47; Q3 revs $18.53B vs. est. $18.78B; as of quarter-end, Disney+ paid subscribers were 118.1M; as of quarter-end ESPN+ paid subscribers were 17.1M; quarter-end, total Hulu paid subscribers were 43.8M; 179M total subscriptions across our DTC portfolio at end of fiscal 2021 and 60% subscriber growth year-over-year for Disney+ Bumble ($BMBL) 3Q EPS ($0.06) vs est. $0.00 on revs $200.5Mm vs est. $198.8Mm (app revs $142Mm, paying users increased to 2.9Mm, total ARPU $22.97 vs $19.38); guides 4Q revs $208-211 vs est. $206Mm, raises FY revs $765-768Mm vs est. $761.6Mm Technology ContextLogic Inc. ($WISH) Q3 EPS (10c) vs est. (15c) on revenue $368M vs est. $353.6M; CEO Piotr Szulczewski will be stepping down; is not providing official Q4 guidance but expects revenue to be lower than Q3 despite the holidays, primarily driven by ongoing reduction in ad spend, and said October revenue is down ~20% vs avg Q3 monthly revenue Cricut Inc. ($CRCT) shares slide -15%; Q3 EPS $0.13 vs. est. $0.16; Q3 revs rose 24.4% to $260.1M vs. est. $256.8M; connected machine revenue was $102.5 million, up 35.7% YoY; subscriptions revenue was $53.3 million, up 70.8% YoY; Accessories and materials revenue was $104.3 million, up 2.0% YoY; gross margin was 39.2%, down from 42.8% YoY Schrodinger, Inc. ($SDGR) Q3 EPS loss (-$0.49) vs. est. loss (-$0.43); Q3 revs rose 16% to $29.9M vs. est. $31.5M; sees FY revs $124M-$134M vs. est. $138.5M

123 Replies 6 πŸ‘ 13 πŸ”₯

profile
@dros #droscrew
recently

Upgrades 9/1: $AAPL $APLE $CLDT $CNI $FARM $PPL $SDGR . Downgrades 9/1: $AMC $AWK $CNI $DTE $FB $KSU $LMRK $RDI

57 Replies 14 πŸ‘ 9 πŸ”₯

profile
@bronco #droscrew
recently

Some other names holding up or green, $RBLX, $AMD, $SDGR, $SNOW. Adding to my list

115 Replies 11 πŸ‘ 9 πŸ”₯

profile
@bronco #droscrew
recently

$SDGR is a great pickup down here as long as $65 holds. Little bites until it turns. Shaw has been a frequent seller as of late. But he seems to like doing that between 70-80.

56 Replies 11 πŸ‘ 13 πŸ”₯

profile
@bronco #droscrew
recently

Well $SDGR failed, tied to $XBI pullback! Still a monster in the waiting

122 Replies 10 πŸ‘ 13 πŸ”₯

profile
@HeyShoe #droscrew
recently

SDGR has been beaten up

128 Replies 11 πŸ‘ 8 πŸ”₯

profile
@bronco #droscrew
recently

$SDGR gonna be a monster!

113 Replies 9 πŸ‘ 9 πŸ”₯

profile
@bronco #droscrew
recently

take some $SDGR on pull backs

86 Replies 9 πŸ‘ 7 πŸ”₯

profile
@bronco #droscrew
recently

πŸ‘ $SDGR could be huge!

138 Replies 6 πŸ‘ 13 πŸ”₯

GM
@gman2 #ivtrades
recently

$SDGR again

133 Replies 7 πŸ‘ 10 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

9769 $SDGR Jul21 85.0 Calls trade $1.05 (FT Theo=0.88) Above Ask! [CBOE] IV=43.6% +1.1 FLOOR - OPENING Vol=10k, OI=240,

93 Replies 14 πŸ‘ 7 πŸ”₯

GM
@gman2 #ivtrades
recently

$SDGR interesting company, no debt on it's balance sheet, on watch

104 Replies 9 πŸ‘ 13 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

1700 $SDGR Aug21 90.0 Calls trade $2.20 (FT Theo=1.99) ASKSIDE PHLX 11:15:07 IV=52.8% +3.5 FLOOR - OPENING Vol=3922, OI=34,

108 Replies 9 πŸ‘ 7 πŸ”₯

OR
@orazzini.piero #decarolis
recently

TELADOC: Il titolo dopo una importante discesa nonostante i fondamentali buoni sembra essersi fermato pertanto ritengo che possa nascere una buona opportunitΓ  d'acquisto STRATEGIA: acquistero in lotti uguali in tre fasi la prima a partire da 135 ~ ed a seguire a 148 ~ fino a quota 160 I miei Target Profit sono piazzati a quota 186 con un incremento del 40 % a quota 215 con un incremento del 60 % e come ultimo a quota 272 con un incremento del 100 %. STOP L a quota 126,50 La stessa analisi si puo applicare al titolo Schrodinger SDGR che graficamente Γ¨ identico a Teladoc mentre attenzionerei anche CERN diretto concorrente di Teladoc. Gradirei un vostro commento sia positivo che negativo.... servira a migliorare l'analisi

98 Replies 6 πŸ‘ 14 πŸ”₯

profile
@HeyShoe #droscrew
recently

tomorrow morning: $FUBO, $SDGR, $JMIA

148 Replies 7 πŸ‘ 7 πŸ”₯

I2
@I2L #droscrew
recently

Ben if your around, what you think of $SDGR ?

52 Replies 12 πŸ‘ 11 πŸ”₯

profile
@HeyShoe #droscrew
recently

$SDGR rummaged

129 Replies 6 πŸ‘ 10 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$SDGR 80C Dec

123 Replies 13 πŸ‘ 11 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$SDGR June 90C

83 Replies 9 πŸ‘ 14 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$SDGR to $76

72 Replies 14 πŸ‘ 12 πŸ”₯

profile
@HeyShoe #droscrew
recently

$SDGR getting love on the feed

112 Replies 10 πŸ‘ 13 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR 20wma support

106 Replies 6 πŸ‘ 15 πŸ”₯

I2
@I2L #droscrew
recently

except for for $SDGR lol

56 Replies 6 πŸ‘ 7 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR keep an eye, ms cathy been adding heavy everyday

142 Replies 14 πŸ‘ 6 πŸ”₯

I2
@I2L #droscrew
recently

ouch SDGR done

144 Replies 10 πŸ‘ 12 πŸ”₯

I2
@I2L #droscrew
recently

Hey dros...do you see any activity in option for SDGR?

61 Replies 7 πŸ‘ 7 πŸ”₯

profile
@Benlax #droscrew
recently

jesus $SDGR

63 Replies 6 πŸ‘ 14 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR probably good now, cathy been buying like crazy

110 Replies 12 πŸ‘ 9 πŸ”₯

I2
@I2L #droscrew
recently

Anyone following $SDGR? Secondary coming but would this be a good spot for entry? Close to the offering price or wait till fully executed?

54 Replies 11 πŸ‘ 13 πŸ”₯

profile
@Benlax #droscrew
recently

Other $SDGR collaborations: $SNY , $TMO $BAYRY $AZN

45 Replies 6 πŸ‘ 12 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR SchrΓΆdinger and Viva Biotech Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets. Collaboration aims to enable the discovery of first-in-class therapeutic candidates.

45 Replies 13 πŸ‘ 9 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR $CRWD looking nice today

121 Replies 9 πŸ‘ 14 πŸ”₯

M2
@M2 #droscrew
recently

but id still be a buyer of tech on dips and im still holding sdgr

130 Replies 10 πŸ‘ 9 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR could be a good spot here to get long

101 Replies 8 πŸ‘ 6 πŸ”₯

profile
@Benlax #droscrew
recently

twlo okta sdgr crwd still look pretty good

102 Replies 12 πŸ‘ 10 πŸ”₯

profile
@Benlax #droscrew
recently

while some look like dip buyers have already been coming strong like crwd, sdgr, okta, twlo

68 Replies 10 πŸ‘ 15 πŸ”₯

I2
@I2L #droscrew
recently

good point Ben...I put SDGR on my list after you mentioned it today

70 Replies 14 πŸ‘ 7 πŸ”₯

profile
@Benlax #droscrew
recently

like sdgr, okta, rng

110 Replies 10 πŸ‘ 7 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR alive

58 Replies 14 πŸ‘ 11 πŸ”₯

profile
@dros #droscrew
recently

then I was looking at SDGR in active trader

132 Replies 15 πŸ‘ 12 πŸ”₯

profile
@Benlax #droscrew
recently

dros buy 1k $SDGR shares real quick and wake it up

95 Replies 9 πŸ‘ 15 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR still sucking air

144 Replies 7 πŸ‘ 6 πŸ”₯

profile
@Benlax #droscrew
recently

man i picked up $SDGR calls today and shits hasnt bounced at all

150 Replies 6 πŸ‘ 11 πŸ”₯

profile
@Benlax #droscrew
recently

$NET $SDGR can get starters here guys

144 Replies 7 πŸ‘ 9 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR good spot to buy here

124 Replies 10 πŸ‘ 13 πŸ”₯

profile
@Benlax #droscrew
recently

$SDGR looks nice still

114 Replies 9 πŸ‘ 7 πŸ”₯

Key Metrics

Market Cap

1.72 B

Beta

1.73

Avg. Volume

684.11 K

Shares Outstanding

61.97 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

SchrΓΆdinger is transforming the way therapeutics and materials are discovered. SchrΓΆdinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. SchrΓΆdinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Website:

HQ: ,

Related News